172 related articles for article (PubMed ID: 36753780)
1. PD-1 blockade augments CD8
Nakasuka T; Ohashi K; Nishii K; Hirabae A; Okawa S; Tomonobu N; Takada K; Ando C; Watanabe H; Makimoto G; Ninomiya K; Fujii M; Kubo T; Ichihara E; Hotta K; Tabata M; Kumon H; Maeda Y; Kiura K
Lung Cancer; 2023 Apr; 178():1-10. PubMed ID: 36753780
[TBL] [Abstract][Full Text] [Related]
2. Promising Gene Therapy Using an Adenovirus Vector Carrying REIC/Dkk-3 Gene for the Treatment of Biliary Cancer.
Tanaka E; Uchida D; Shiraha H; Kato H; Ohyama A; Iwamuro M; Watanabe M; Kumon H; Okada H
Curr Gene Ther; 2020; 20(1):64-70. PubMed ID: 32148193
[TBL] [Abstract][Full Text] [Related]
3. Promising therapeutic efficacy of a novel reduced expression in immortalized cells/dickkopf-3 expressing adenoviral vector for hepatocellular carcinoma.
Sawahara H; Shiraha H; Uchida D; Kato H; Kato R; Oyama A; Nagahara T; Iwamuro M; Horiguchi S; Tsutsumi K; Mandai M; Mimura T; Wada N; Takeuchi Y; Kuwaki K; Onishi H; Nakamura S; Watanabe M; Sakaguchi M; Takaki A; Nouso K; Yagi T; Nasu Y; Kumon H; Okada H
J Gastroenterol Hepatol; 2017 Oct; 32(10):1769-1777. PubMed ID: 28168749
[TBL] [Abstract][Full Text] [Related]
4. CD8+ T-cell Responses Are Boosted by Dual PD-1/VEGFR2 Blockade after EGFR Inhibition in Egfr-Mutant Lung Cancer.
Nishii K; Ohashi K; Tomida S; Nakasuka T; Hirabae A; Okawa S; Nishimura J; Higo H; Watanabe H; Kano H; Ando C; Makimoto G; Ninomiya K; Kato Y; Kubo T; Ichihara E; Hotta K; Tabata M; Toyooka S; Udono H; Maeda Y; Kiura K
Cancer Immunol Res; 2022 Sep; 10(9):1111-1126. PubMed ID: 35802887
[TBL] [Abstract][Full Text] [Related]
5. Anti-cancer effects of REIC/Dkk-3-encoding adenoviral vector for the treatment of non-small cell lung cancer.
Shien K; Tanaka N; Watanabe M; Soh J; Sakaguchi M; Matsuo K; Yamamoto H; Furukawa M; Asano H; Tsukuda K; Nasu Y; Huh NH; Miyoshi S; Kumon H; Toyooka S
PLoS One; 2014; 9(2):e87900. PubMed ID: 24498395
[TBL] [Abstract][Full Text] [Related]
6. Distant Bystander Effect of REIC/DKK3 Gene Therapy Through Immune System Stimulation in Thoracic Malignancies.
Suzawa K; Shien K; Peng H; Sakaguchi M; Watanabe M; Hashida S; Maki Y; Yamamoto H; Tomida S; Soh J; Asano H; Tsukuda K; Nasu Y; Kumon H; Miyoshi S; Toyooka S
Anticancer Res; 2017 Jan; 37(1):301-307. PubMed ID: 28011506
[TBL] [Abstract][Full Text] [Related]
7. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
8. Clinical relevance of PD-L1 expression and CD8+ T cells infiltration in patients with EGFR-mutated and ALK-rearranged lung cancer.
Liu SY; Dong ZY; Wu SP; Xie Z; Yan LX; Li YF; Yan HH; Su J; Yang JJ; Zhou Q; Zhong WZ; Tu HY; Yang XN; Zhang XC; Wu YL
Lung Cancer; 2018 Nov; 125():86-92. PubMed ID: 30429043
[TBL] [Abstract][Full Text] [Related]
9. A novel gene expression system strongly enhances the anticancer effects of a REIC/Dkk-3-encoding adenoviral vector.
Watanabe M; Sakaguchi M; Kinoshita R; Kaku H; Ariyoshi Y; Ueki H; Tanimoto R; Ebara S; Ochiai K; Futami J; Li SA; Huang P; Nasu Y; Huh NH; Kumon H
Oncol Rep; 2014 Mar; 31(3):1089-95. PubMed ID: 24398705
[TBL] [Abstract][Full Text] [Related]
10. Molecular heterogeneity of anti-PD-1/PD-L1 immunotherapy efficacy is correlated with tumor immune microenvironment in East Asian patients with non-small cell lung cancer.
Jin R; Liu C; Zheng S; Wang X; Feng X; Li H; Sun N; He J
Cancer Biol Med; 2020 Aug; 17(3):768-781. PubMed ID: 32944405
[No Abstract] [Full Text] [Related]
11. A super gene expression system enhances the anti-glioma effects of adenovirus-mediated REIC/Dkk-3 gene therapy.
Oka T; Kurozumi K; Shimazu Y; Ichikawa T; Ishida J; Otani Y; Shimizu T; Tomita Y; Sakaguchi M; Watanabe M; Nasu Y; Kumon H; Date I
Sci Rep; 2016 Sep; 6():33319. PubMed ID: 27625116
[TBL] [Abstract][Full Text] [Related]
12. PD-L1 expression and T cells infiltration in patients with uncommon EGFR-mutant non-small cell lung cancer and the response to immunotherapy.
Chen K; Cheng G; Zhang F; Zhu G; Xu Y; Yu X; Huang Z; Fan Y
Lung Cancer; 2020 Apr; 142():98-105. PubMed ID: 32120230
[TBL] [Abstract][Full Text] [Related]
13. Novel REIC/Dkk-3-encoding adenoviral vector as a promising therapeutic agent for pancreatic cancer.
Sawahara H; Shiraha H; Uchida D; Kato H; Nagahara T; Iwamuro M; Kataoka J; Horiguchi S; Watanabe M; Sakaguchi M; Takaki A; Nouso K; Nasu Y; Kumon H; Okada H
Cancer Gene Ther; 2016 Aug; 23(8):278-83. PubMed ID: 27468808
[TBL] [Abstract][Full Text] [Related]
14. Concurrent High PD-L1 Expression and CD8
Shimoda Y; Shibaki R; Yoshida T; Murakami S; Shirasawa M; Torasawa M; Matsumoto Y; Masuda K; Shinno Y; Okuma Y; Goto Y; Horinouchi H; Yamamoto N; Ohe Y; Motoi N
Clin Lung Cancer; 2022 Sep; 23(6):477-486. PubMed ID: 35644780
[TBL] [Abstract][Full Text] [Related]
15. Combination of ultrasound-based mechanical disruption of tumor with immune checkpoint blockade modifies tumor microenvironment and augments systemic antitumor immunity.
Abe S; Nagata H; Crosby EJ; Inoue Y; Kaneko K; Liu CX; Yang X; Wang T; Acharya CR; Agarwal P; Snyder J; Gwin W; Morse MA; Zhong P; Lyerly HK; Osada T
J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35039461
[TBL] [Abstract][Full Text] [Related]
16. Combination of Ad-SGE-REIC and bevacizumab modulates glioma progression by suppressing tumor invasion and angiogenesis.
Hattori Y; Kurozumi K; Otani Y; Uneda A; Tsuboi N; Makino K; Hirano S; Fujii K; Tomita Y; Oka T; Matsumoto Y; Shimazu Y; Michiue H; Kumon H; Date I
PLoS One; 2022; 17(8):e0273242. PubMed ID: 36006934
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-10 induces expression of CD39 on CD8+T cells to potentiate anti-PD1 efficacy in EGFR-mutated non-small cell lung cancer.
Qiao M; Zhou F; Liu X; Jiang T; Wang H; Jia Y; Li X; Zhao C; Cheng L; Chen X; Ren S; Liu H; Zhou C
J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36543373
[TBL] [Abstract][Full Text] [Related]
18. Blockade of EGFR improves responsiveness to PD-1 blockade in
Sugiyama E; Togashi Y; Takeuchi Y; Shinya S; Tada Y; Kataoka K; Tane K; Sato E; Ishii G; Goto K; Shintani Y; Okumura M; Tsuboi M; Nishikawa H
Sci Immunol; 2020 Jan; 5(43):. PubMed ID: 32005679
[TBL] [Abstract][Full Text] [Related]
19. Association of CD8 T cell apoptosis and EGFR mutation in non-small lung cancer patients.
Zhao C; Su C; Li X; Zhou C
Thorac Cancer; 2020 Aug; 11(8):2130-2136. PubMed ID: 32500560
[TBL] [Abstract][Full Text] [Related]
20. Targeting the ERĪ²/HER Oncogenic Network in
Almotlak AA; Farooqui M; Soloff AC; Siegfried JM; Stabile LP
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
